Optical Imaging with a Cathepsin B Activated Probe for the Enhanced Detection of Esophageal Adenocarcinoma by Dual Channel Fluorescent Upper GI Endoscopy

Despite significant advances in diagnosis and treatment, the prognosis of esophageal adenocarcinoma remains poor highlighting the importance of early detection. Although white light (WL) upper endoscopy can be used for screening of the esophagus, it has limited sensitivity for early stage disease. Thus, development of new imaging technology to improve the diagnostic capabilities of upper GI endoscopy for early detection of esophageal adenocarcinoma is an important unmet need. The goal of this study was to develop a method for the detection of malignant lesions in the esophagus using WL upper endoscopy combined with near infrared (NIR) imaging with a protease activatable probe (Prosense750) selective for cathepsin B (CTSB). An orthotopic murine model for distal esophageal adenocarcinoma was generated through the implantation of OE-33 and OE-19 human esophageal adenocarcinoma lines in immunocompromised mice. The mice were imaged simultaneously for WL and NIR signal using a custom-built dual channel upper GI endoscope. The presence of tumor was confirmed by histology and target to background ratios (TBR) were compared for both WL and NIR imaging. NIR imaging with ProSense750 significantly improved upon the TBRs of esophageal tumor foci, with a TBR of 3.64±0.14 and 4.50±0.11 for the OE-33 and OE-19 tumors respectively, compared to 0.88±0.04 and 0.81±0.02 TBR for WL imaging. The combination of protease probes with novel imaging devices has the potential to improve esophageal tumor detection by fluorescently highlighting neoplastic regions.

[1]  Thomas D. Wang,et al.  Molecular Imaging for Guiding Oncologic Prognosis and Therapy in Esophageal Adenocarcinoma , 2011, Hospital practice.

[2]  S. Parsons.  Are we missing Gastro-Oesophageal Cancer at Endoscopy? , 2010, Annals of the Royal College of Surgeons of England.

[3]  Ralph Weissleder,et al.  Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical model. , 2009, Gynecologic oncology.

[4]  Ralph Weissleder,et al.  Quantitative real-time catheter-based fluorescence molecular imaging in mice. , 2007, Radiology.

[5]  Hisataka Kobayashi,et al.  A Self-Quenched Galactosamine-Serum Albumin-RhodamineX Conjugate: A “Smart” Fluorescent Molecular Imaging Probe Synthesized with Clinically Applicable Material for Detecting Peritoneal Ovarian Cancer Metastases , 2007, Clinical Cancer Research.

[6]  Hisataka Kobayashi,et al.  Activatable fluorescent molecular imaging of peritoneal metastases following pretargeting with a biotinylated monoclonal antibody. , 2007, Cancer research.

[7]  M. Wallace,et al.  Molecular imaging in gastrointestinal disease. , 2007, Gastroenterology.

[8]  R. Weissleder,et al.  Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer , 2006, International journal of cancer.

[9]  A. Roessner,et al.  Interactions between human colon carcinoma cells, fibroblasts and monocytic cells in coculture--regulation of cathepsin B expression and invasiveness. , 2005, Cancer letters.

[10]  H. Welch,et al.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.

[11]  Ralph Weissleder,et al.  Catheter-based in vivo imaging of enzyme activity and gene expression: feasibility study in mice. , 2004, Radiology.

[12]  Ralph Weissleder,et al.  Miniaturized multichannel near infrared endoscope for mouse imaging. , 2003, Molecular imaging.

[13]  L. Bonavina,et al.  Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus , 2002, Surgical Endoscopy And Other Interventional Techniques.

[14]  Y. Nakamura,et al.  Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. , 2000, Cancer research.

[15]  S. Hanash,et al.  A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene. , 2000, Cancer research.

[16]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[17]  Dawn Provenzale,et al.  Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk , 1999, American Journal of Gastroenterology.

[18]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[19]  S Hanash,et al.  A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Bonnie F. Sloane.  Cathepsin B and cystatins: evidence for a role in cancer progression. , 1990, Seminars in cancer biology.